volume 100, issue 2, P243-248 2020
DOI: 10.1002/cyto.b.21865
View full text
|
|
Share
Katrina Collins, Jolene L. Cardinali, Laila O. Mnayer, Joseph A. DiGiuseppe

Abstract: Background: CD49f (integrin α6) is a useful marker for minimal residual disease (MRD) detection in B lymphoblastic leukemia and has recently been suggested to mediate infiltration of the central nervous system by leukemic B lymphoblasts. However, data regarding expression of CD49f protein in B lymphoblastic leukemia are limited, and whether CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia is unknown. Methods: CD49f protein expression was characterized by flow cytometry in a s…

expand abstract